Back to Search Start Over

Advances in therapeutic applications of extracellular vesicles

Authors :
Oscar P. B. Wiklander
Jan Lötvall
Meadhbh Á. Brennan
Xandra O. Breakefield
Samir El Andaloussi
Karolinska Institutet [Stockholm]
Evox Therapeutics Limited
Partenaires INRAE
Sarcomes osseux et remodelage des tissus calcifiés - Phy-Os [Nantes - INSERM U1238] (Phy-Os)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Bretagne Loire (UBL)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)
Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS)
Harvard University [Cambridge]
Massachusetts General Hospital [Boston]
Harvard Medical School [Boston] (HMS)
M.A.B. was supported by Marie Skłodowska Curie Individual Fellowship PARAGEN H2020-MSCA-IF-2015-708711. J.L. was supported by the Swedish Cancer Foundation (Dnr 2014/844 and 2017/739), the Swedish Heart and Lung Foundation (Dnr 20150588), the Swedish Research Council (Dnr 2016-02854), and the VBG Group Herman Krefting Foundation for Asthma and Allergy Research. X.O.B. was supported by NIH NCI grants U19 CA179563, P01 CA069246, and R35 CA232103-01. S.EL.A. was supported by Swedish Research Council (VR-Med) and Swedish Strategic Science Foundation (SSF-IRC).
Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Bretagne Loire (UBL)-Centre hospitalier universitaire de Nantes (CHU Nantes)
brennan, meadhbh
Source :
Science Translational Medicine, Science Translational Medicine, American Association for the Advancement of Science, 2019, 11 (492), pp.eaav8521, Science Translational Medicine, American Association for the Advancement of Science (AAAS), 2019, 11 (492), pp.eaav8521
Publication Year :
2019
Publisher :
American Association for the Advancement of Science (AAAS), 2019.

Abstract

International audience; Extracellular vesicles (EVs) are nanometer-sized, lipid membrane-enclosed vesicles secreted by most, if not all, cells and contain lipids, proteins, and various nucleic acid species of the source cell. EVs act as important mediators of intercellular communication that influence both physiological and pathological conditions. Given their ability to transfer bioactive components and surmount biological barriers, EVs are increasingly being explored as potential therapeutic agents. EVs can potentiate tissue regeneration, participate in immune modulation, and function as potential alternatives to stem cell therapy, and bioengineered EVs can act as delivery vehicles for therapeutic agents. Here, we cover recent approaches and advances of EV-based therapies.

Details

ISSN :
19466242 and 19466234
Volume :
11
Database :
OpenAIRE
Journal :
Science Translational Medicine
Accession number :
edsair.doi.dedup.....f679e7a7ca11b9de182a17eb064e4488